{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:03:46Z","timestamp":1773968626721,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.annepidem.2008.08.099","type":"journal-article","created":{"date-parts":[[2008,12,8]],"date-time":"2008-12-08T05:41:30Z","timestamp":1228714890000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Endometrial Hyperplasia Risk in Relation to Recent Use of Oral Contraceptives and Hormone Therapy"],"prefix":"10.1016","volume":"19","author":[{"given":"Meira","family":"Epplein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan D.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda F.","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria L.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2008.08.099_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia: A long-term study of 'untreated' hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.annepidem.2008.08.099_bib2","series-title":"Blaustein's pathology of the female genital tract","year":"1994"},{"key":"10.1016\/j.annepidem.2008.08.099_bib3","series-title":"Pathology & Genetics: Tumours of the Breast and Female Genital Organs","first-page":"221","article-title":"Tumours of the uterine corpus: epithelial tumours and related lesions","author":"Silverberg","year":"2003"},{"key":"10.1016\/j.annepidem.2008.08.099_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9378(89)90103-8","article-title":"The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia","volume":"160","author":"Ferenczy","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annepidem.2008.08.099_bib5","first-page":"373","article-title":"Norethindrone acetate and estradiol-induced endometrial hyperplasia","volume":"96","author":"Kurman","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annepidem.2008.08.099_bib6","first-page":"2141","article-title":"Spontaneous endometrial hyperplasia: a prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years","volume":"14","author":"Lindahl","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1016\/j.annepidem.2008.08.099_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/gyno.1994.1249","article-title":"The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia","volume":"55","author":"Hunter","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.annepidem.2008.08.099_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.curobgyn.2003.12.002","article-title":"Endometrial hyperplasia","volume":"14","author":"Hammond","year":"2004","journal-title":"Curr Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.annepidem.2008.08.099_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ijgc-00009577-200403000-00023","article-title":"Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment","volume":"14","author":"Horn","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.annepidem.2008.08.099_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bjc.6604102","article-title":"Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan","volume":"98","author":"Lacey","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annepidem.2008.08.099_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/endo-96-1-160","article-title":"Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei","volume":"96","author":"Anderson","year":"1975","journal-title":"Endocrinology"},{"key":"10.1016\/j.annepidem.2008.08.099_bib12","first-page":"287","article-title":"Hormone-dependence of endometrial cancer","volume":"30","author":"Gusberg","year":"1967","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annepidem.2008.08.099_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women: The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"275","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2008.08.099_bib14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jama.1996.03540170041030","article-title":"The Comparative Effect on Bone Density, Endometrium, and Lipids of Continuous Hormones as Replacement Therapy (CHART Study): A Randomized Controlled Trial","volume":"276","author":"Speroff","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2008.08.099_bib15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0002-9378(98)70553-8","article-title":"Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995","volume":"178","author":"Pickar","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annepidem.2008.08.099_bib16","article-title":"Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding","volume":"2","author":"Lethaby","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.annepidem.2008.08.099_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09513590009167694","article-title":"Low incidence of endometrial hyperplasia with acceptable bleeding patterns in women taking sequential hormone replacement therapy with hydrogesterone","volume":"14","author":"Bergeron","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.annepidem.2008.08.099_bib18","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1067\/mob.2000.108081","article-title":"Continuous combined hormone replacement therapy and risk of endometrial cancer","volume":"183","author":"Hill","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"13","key":"10.1016\/j.annepidem.2008.08.099_bib19","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","article-title":"Risk of endometrial cancer following estrogen replacement with and without progestins","volume":"91","author":"Wiederpass","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"7358","key":"10.1016\/j.annepidem.2008.08.099_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.325.7358.239","article-title":"Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study","volume":"325","author":"Wells","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.annepidem.2008.08.099_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/oxfordjournals.aje.a114237","article-title":"Risk factors for adenomatous endometrial hyperplasia: a case-control study","volume":"123","author":"Kreiger","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2008.08.099_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ijgc-00009577-200205000-00004","article-title":"Risk factors for endometrial hyperplasia: results from a case-control study","volume":"12","author":"Ricci","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.annepidem.2008.08.099_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/aje\/kwn168","article-title":"Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history","volume":"168","author":"Epplein","year":"2008","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.annepidem.2008.08.099_bib24","series-title":"Statistical Methods in Cancer Research, Volume I: The Analysis of Case-Control Studies","author":"Breslow","year":"1980"},{"key":"10.1016\/j.annepidem.2008.08.099_bib25","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archinte.1994.00420120047005","article-title":"The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women","volume":"154","author":"Psaty","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.annepidem.2008.08.099_bib26","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM198112313052701","article-title":"Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium","volume":"305","author":"Whitehead","year":"1981","journal-title":"N Engl Med"},{"key":"10.1016\/j.annepidem.2008.08.099_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9378(97)70502-7","article-title":"Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study)","volume":"176","author":"Korhonen","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annepidem.2008.08.099_bib28","series-title":"Cancer epidemiology and prevention","first-page":"1027","article-title":"Endometrial cancer","author":"Cook","year":"2006"},{"issue":"6 Suppl","key":"10.1016\/j.annepidem.2008.08.099_bib29","first-page":"15","article-title":"Benefits and risks of oral contraceptives","author":"Drife","year":"1990","journal-title":"Adv Contracept"},{"key":"10.1016\/j.annepidem.2008.08.099_bib30","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM198010303031807","article-title":"Decreased risk of endometrial cancer among oral-contraceptive users","volume":"303","author":"Kaufman","year":"1980","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.annepidem.2008.08.099_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/modpathol.3880050","article-title":"Hormonal pathology of the endometrium","volume":"13","author":"Deligdisch","year":"2000","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.annepidem.2008.08.099_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.contraception.2007.11.006","article-title":"Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo","volume":"77","author":"Anderson","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.annepidem.2008.08.099_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0010-7824(99)00076-1","article-title":"Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free interval","volume":"60","author":"Archer","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.annepidem.2008.08.099_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/13625189609150678","article-title":"The effects of a low-dose gestodene-containing oral contraceptive on endometrial histology in healthy women","volume":"1","author":"Coenen","year":"1996","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.annepidem.2008.08.099_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.contraception.2006.07.009","article-title":"Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 mcg\/ethinyl estradiol 20 mcg","volume":"75","author":"Johnson","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.annepidem.2008.08.099_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/1047-2797(93)90035-3","article-title":"Postmenopausal unopposed estrogens: characteristics of use in relation to risk of endometrial carcinoma","volume":"3","author":"Herrington","year":"1993","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2008.08.099_bib37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annepidem.2008.08.099_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0015-0282(01)01828-3","article-title":"Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"76","author":"Pickar","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.annepidem.2008.08.099_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00042192-200203000-00009","article-title":"Low dose transdermal estradiol\/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women","volume":"9","author":"Brynhildsen","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.annepidem.2008.08.099_bib40","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.annepidem.2008.08.099_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1447-0756.1997.tb00836.x","article-title":"The behavior of endometrial hyperplasia: a prospective study","volume":"23","author":"Terakawa","year":"1997","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.annepidem.2008.08.099_bib42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0140-6736(91)90417-N","article-title":"Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer","volume":"338","author":"Voigt","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2008.08.099_bib43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jnci\/89.15.1110","article-title":"Estrogen-progestin replacement therapy and endometrial cancer","volume":"89","author":"Pike","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279708002846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279708002846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:06:19Z","timestamp":1760925979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279708002846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1047279708002846"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2008.08.099","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrial Hyperplasia Risk in Relation to Recent Use of Oral Contraceptives and Hormone Therapy","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2008.08.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}